top of page







AXIOM CROSSROADS SUMMIT
The biopharma ecosystem stands at a crossroads. With anemic R&D delivery, failed clinical trials, access challenges, declining valuations, escalating clinical trial costs, patient identification, the hurdles we face are significant. Listen to leading experts from academia, biopharma, and the investment community discuss strategies to navigate these in oncology and rare diseases.
SUMMIT FACULTY
SUMMIT SESSIONS
All Categories

SEE YOU AT THE
AXIOM CROSSROADS SUMMIT
2025
bottom of page